Considerations in the approach to invasive fungal infection in patients with haematological malignancies.

Considerations in the approach to invasive fungal infection in patients with haematological malignancies.

Item
http://www.wikidata.org/entity/Q37049537
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Invasive aspergillosis due to Neosartorya udagawaeCanadian clinical practice guidelines for invasive candidiasis in adults.Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity.Invasive fungal infections in acute leukemia.Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.Current status of antifungal resistance and its impact on clinical practice.Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
P2860

Considerations in the approach to invasive fungal infection in patients with haematological malignancies.

Item
http://www.wikidata.org/entity/Q37049537
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Considerations in the approach ...... h haematological malignancies.
@en
Considerations in the approach ...... h haematological malignancies.
@nl
type
label
Considerations in the approach ...... h haematological malignancies.
@en
Considerations in the approach ...... h haematological malignancies.
@nl
prefLabel
Considerations in the approach ...... h haematological malignancies.
@en
Considerations in the approach ...... h haematological malignancies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Considerations in the approach ...... h haematological malignancies.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2141.2007.06906.X
P407
P433
P478
P577
P5875
P698